Oncology Economist Impact: World Cancer Series – pharmaphorum in atte... Taking a brief look back to pharmaphorum’s coverage of Day One of The Economist’s 8th Annual
News Lilly points to long-lasting weight loss with orforglipron Lilly breaks new ground for oral GLP-1 agonists with data showing it can help patients keep weight off after treatment with injectable therapies.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.